Stop-AD Centre
The main objective of the StoP-Alzheimer Center is to pursue innovative studies on the “pre-symptomatic” phase of Alzheimer’s disease using measures of various disease indicators, including genetic variants, brain imaging, cerebrospinal fluid collection, neurosensory markers, as well as lifestyle questionnaires, cognitive and medical assessments. Director Sylvia Villeneuve, PhD Associate Director Judes Poirier, PhD, MD (Hon), CQ … Read more